

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.49940018 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.49940018 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.49940018 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.49940018 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.49940018 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.49940018 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.86042067 |
| 8 | response to muramyl dipeptide (GO:0032495) | 4.48516773 |
| 9 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.37543271 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.32789759 |
| 11 | negative thymic T cell selection (GO:0045060) | 4.30144255 |
| 12 | negative T cell selection (GO:0043383) | 4.26535651 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.24891545 |
| 14 | NIK/NF-kappaB signaling (GO:0038061) | 4.15089857 |
| 15 | response to peptidoglycan (GO:0032494) | 4.10590635 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.05062046 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.00135159 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.88876717 |
| 19 | positive regulation of interferon-alpha production (GO:0032727) | 3.87304773 |
| 20 | thymic T cell selection (GO:0045061) | 3.84719625 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 3.78795938 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.76603077 |
| 23 | T cell selection (GO:0045058) | 3.71441372 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.63984880 |
| 25 | B cell receptor signaling pathway (GO:0050853) | 3.62824286 |
| 26 | leukocyte aggregation (GO:0070486) | 3.62554678 |
| 27 | germinal center formation (GO:0002467) | 3.57934791 |
| 28 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.57848115 |
| 29 | natural killer cell mediated immunity (GO:0002228) | 3.57848115 |
| 30 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.55360636 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.55296974 |
| 32 | positive regulation of heat generation (GO:0031652) | 3.55283498 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.53098509 |
| 34 | response to host immune response (GO:0052572) | 3.53098509 |
| 35 | response to interleukin-15 (GO:0070672) | 3.50976847 |
| 36 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.44431675 |
| 37 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.43019920 |
| 38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.42192825 |
| 39 | positive thymic T cell selection (GO:0045059) | 3.42123149 |
| 40 | positive regulation of interleukin-12 production (GO:0032735) | 3.42063316 |
| 41 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.41813505 |
| 42 | negative regulation of T cell mediated immunity (GO:0002710) | 3.41564869 |
| 43 | myeloid dendritic cell differentiation (GO:0043011) | 3.38259090 |
| 44 | histone H3-K36 demethylation (GO:0070544) | 3.37572584 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.37237899 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 3.32125783 |
| 47 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.31802964 |
| 48 | response to host defenses (GO:0052200) | 3.30883394 |
| 49 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.30883394 |
| 50 | response to host (GO:0075136) | 3.30883394 |
| 51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.30076548 |
| 52 | myeloid dendritic cell activation (GO:0001773) | 3.29421930 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.28778982 |
| 54 | neutrophil mediated immunity (GO:0002446) | 3.27545767 |
| 55 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.26116804 |
| 56 | I-kappaB phosphorylation (GO:0007252) | 3.25348228 |
| 57 | detection of other organism (GO:0098543) | 3.24781964 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.23375918 |
| 59 | granulocyte activation (GO:0036230) | 3.22669232 |
| 60 | hepatocyte apoptotic process (GO:0097284) | 3.21689911 |
| 61 | positive regulation of interferon-beta production (GO:0032728) | 3.21101871 |
| 62 | cellular response to interleukin-15 (GO:0071350) | 3.21015695 |
| 63 | activated T cell proliferation (GO:0050798) | 3.19963637 |
| 64 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.17871173 |
| 65 | neutrophil activation (GO:0042119) | 3.17396017 |
| 66 | regulation of T cell tolerance induction (GO:0002664) | 3.15226288 |
| 67 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.14725718 |
| 68 | regulation of fever generation (GO:0031620) | 3.14612578 |
| 69 | detection of bacterium (GO:0016045) | 3.14594120 |
| 70 | negative regulation of interleukin-12 production (GO:0032695) | 3.14481860 |
| 71 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.13667781 |
| 72 | positive regulation of granulocyte differentiation (GO:0030854) | 3.12419047 |
| 73 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.12024403 |
| 74 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.10718156 |
| 75 | T-helper cell differentiation (GO:0042093) | 3.10718156 |
| 76 | cytokine secretion (GO:0050663) | 3.10441417 |
| 77 | regulation of chronic inflammatory response (GO:0002676) | 3.09843878 |
| 78 | detection of molecule of bacterial origin (GO:0032490) | 3.09506855 |
| 79 | regulation of histone H3-K27 methylation (GO:0061085) | 3.05835596 |
| 80 | positive regulation of B cell differentiation (GO:0045579) | 3.05473153 |
| 81 | defense response to protozoan (GO:0042832) | 3.05443162 |
| 82 | positive regulation of humoral immune response (GO:0002922) | 3.05380585 |
| 83 | * modulation by symbiont of host cellular process (GO:0044068) | 3.04698344 |
| 84 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.02839584 |
| 85 | regulation of interleukin-12 production (GO:0032655) | 3.01862542 |
| 86 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.99208055 |
| 87 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.97911418 |
| 88 | positive regulation of antigen processing and presentation (GO:0002579) | 2.95198324 |
| 89 | respiratory burst (GO:0045730) | 2.94553485 |
| 90 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.93988550 |
| 91 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.93988550 |
| 92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93248105 |
| 93 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.92915793 |
| 94 | detection of biotic stimulus (GO:0009595) | 2.91572249 |
| 95 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.90837562 |
| 96 | leukocyte cell-cell adhesion (GO:0007159) | 2.90432131 |
| 97 | negative regulation of cell killing (GO:0031342) | 2.89484728 |
| 98 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89484728 |
| 99 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.88702484 |
| 100 | regulation of necroptotic process (GO:0060544) | 2.86953293 |
| 101 | interferon-gamma production (GO:0032609) | 2.86804716 |
| 102 | regulation of tolerance induction (GO:0002643) | 2.86176594 |
| 103 | microglial cell activation (GO:0001774) | 2.85934554 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 2.85861378 |
| 105 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.85718171 |
| 106 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.85387710 |
| 107 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.85178513 |
| 108 | positive regulation of interleukin-2 production (GO:0032743) | 2.85083953 |
| 109 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.84074214 |
| 110 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.83743870 |
| 111 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.81785981 |
| 112 | positive regulation of isotype switching (GO:0045830) | 2.80518845 |
| 113 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.80487099 |
| 114 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.79747222 |
| 115 | positive regulation of B cell mediated immunity (GO:0002714) | 2.79649819 |
| 116 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.79649819 |
| 117 | positive T cell selection (GO:0043368) | 2.78983960 |
| 118 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.78130029 |
| 119 | * B cell homeostasis (GO:0001782) | 2.78030302 |
| 120 | response to protozoan (GO:0001562) | 2.77603048 |
| 121 | wound healing, spreading of epidermal cells (GO:0035313) | 2.77378271 |
| 122 | tolerance induction (GO:0002507) | 2.77027411 |
| 123 | negative regulation of lipid storage (GO:0010888) | 2.77011716 |
| 124 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.76831277 |
| 125 | response to type I interferon (GO:0034340) | 2.76786398 |
| 126 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.75513729 |
| 127 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.75000764 |
| 128 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.75000764 |
| 129 | T cell differentiation involved in immune response (GO:0002292) | 2.75000764 |
| 130 | cellular response to type I interferon (GO:0071357) | 2.74505694 |
| 131 | type I interferon signaling pathway (GO:0060337) | 2.74505694 |
| 132 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.73304842 |
| 133 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.73099224 |
| 134 | T cell migration (GO:0072678) | 2.72446485 |
| 135 | cellular extravasation (GO:0045123) | 2.71929264 |
| 136 | regulation of integrin activation (GO:0033623) | 2.71560261 |
| 137 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.71292698 |
| 138 | regulation of interleukin-1 secretion (GO:0050704) | 2.70568062 |
| 139 | cell adhesion mediated by integrin (GO:0033627) | 2.70487973 |
| 140 | regulation of chemokine biosynthetic process (GO:0045073) | 2.70481517 |
| 141 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.68549968 |
| 142 | necroptotic process (GO:0070266) | 2.67816206 |
| 143 | regulation of B cell differentiation (GO:0045577) | 2.67806377 |
| 144 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67662727 |
| 145 | macrophage activation (GO:0042116) | 2.67365757 |
| 146 | regulation of B cell proliferation (GO:0030888) | 2.67194414 |
| 147 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.66540972 |
| 148 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.66335299 |
| 149 | natural killer cell activation involved in immune response (GO:0002323) | 2.66201942 |
| 150 | positive regulation of B cell proliferation (GO:0030890) | 2.64155936 |
| 151 | regulation of regulatory T cell differentiation (GO:0045589) | 2.64085036 |
| 152 | B cell proliferation (GO:0042100) | 2.63973901 |
| 153 | positive regulation of tolerance induction (GO:0002645) | 2.63780483 |
| 154 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.63591134 |
| 155 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.63591134 |
| 156 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.63211286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.48128950 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.39416836 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.73878864 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.61875355 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.42672416 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.21424874 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.91036135 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.77749981 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.60124314 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.36555571 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.36386299 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.36107139 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.33796409 |
| 14 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.26003246 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.25543251 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.10086679 |
| 17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.94503314 |
| 18 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.87240698 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.63045092 |
| 20 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.52075610 |
| 21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31433058 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.22295580 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.20520642 |
| 24 | * MYB_26560356_Chip-Seq_TH2_Human | 2.17450134 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.17209508 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12107761 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.07779286 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99513528 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.98498231 |
| 30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.97627630 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.95884425 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.95139564 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.93474857 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.90745849 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.89564607 |
| 36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.83615813 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.79803147 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.75575095 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73908710 |
| 40 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.72911484 |
| 41 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.71673964 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66448212 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.58911959 |
| 44 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56342320 |
| 45 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55535318 |
| 46 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.54212369 |
| 47 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51184937 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46884405 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46505342 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46110661 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42247426 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39398007 |
| 53 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38066950 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36887017 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.36454888 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35351742 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30589736 |
| 58 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30420852 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27772144 |
| 60 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27488659 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25282669 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22768101 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22067273 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17857981 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14787259 |
| 66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.13723257 |
| 67 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.13639402 |
| 68 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12644571 |
| 69 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11069681 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10808016 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10383071 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09551268 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08503349 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07370005 |
| 75 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05674590 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04539074 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.03829514 |
| 78 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02498365 |
| 79 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02348151 |
| 80 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.01349043 |
| 81 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01344092 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99289442 |
| 83 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.98392620 |
| 84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97828360 |
| 85 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97616300 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95798251 |
| 87 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94896230 |
| 88 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94896230 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94894102 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92777896 |
| 91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92391744 |
| 92 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92293429 |
| 93 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.92135562 |
| 94 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.90984352 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90382477 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88878612 |
| 97 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88623804 |
| 98 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87928682 |
| 99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87064784 |
| 100 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85882337 |
| 101 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85327661 |
| 102 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.82960715 |
| 103 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82846155 |
| 104 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.79597178 |
| 105 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78502034 |
| 106 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.77987389 |
| 107 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.77987389 |
| 108 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.77987389 |
| 109 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.77664338 |
| 110 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.77270025 |
| 111 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76761002 |
| 112 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.76147903 |
| 113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76105743 |
| 114 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.75095852 |
| 115 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74750358 |
| 116 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.74409461 |
| 117 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.73574041 |
| 118 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72223877 |
| 119 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68491445 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67590865 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67467384 |
| 122 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.67188374 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.66826639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.96339118 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.93339189 |
| 3 | MP0003436_decreased_susceptibility_to | 3.30318357 |
| 4 | MP0003303_peritoneal_inflammation | 3.09703066 |
| 5 | MP0009785_altered_susceptibility_to | 3.09491474 |
| 6 | * MP0005000_abnormal_immune_tolerance | 2.88101571 |
| 7 | MP0001790_abnormal_immune_system | 2.80018222 |
| 8 | MP0005387_immune_system_phenotype | 2.80018222 |
| 9 | MP0009278_abnormal_bone_marrow | 2.78361350 |
| 10 | * MP0001800_abnormal_humoral_immune | 2.77961657 |
| 11 | MP0000685_abnormal_immune_system | 2.76846891 |
| 12 | MP0005671_abnormal_response_to | 2.76314761 |
| 13 | MP0002419_abnormal_innate_immunity | 2.76268937 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.73698016 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.69743443 |
| 16 | MP0006082_CNS_inflammation | 2.63198108 |
| 17 | * MP0002723_abnormal_immune_serum | 2.55674016 |
| 18 | * MP0005025_abnormal_response_to | 2.53261949 |
| 19 | MP0004510_myositis | 2.47503732 |
| 20 | MP0004947_skin_inflammation | 2.38979879 |
| 21 | * MP0001819_abnormal_immune_cell | 2.30615625 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.28988226 |
| 23 | MP0002009_preneoplasia | 2.11830625 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.08416800 |
| 25 | MP0005451_abnormal_body_composition | 2.07682189 |
| 26 | MP0002405_respiratory_system_inflammati | 2.03612359 |
| 27 | MP0003448_altered_tumor_morphology | 1.91913289 |
| 28 | MP0002006_tumorigenesis | 1.91591017 |
| 29 | MP0003724_increased_susceptibility_to | 1.89479506 |
| 30 | * MP0002398_abnormal_bone_marrow | 1.86873215 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.86020772 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.83820900 |
| 33 | * MP0000716_abnormal_immune_system | 1.77737947 |
| 34 | MP0005076_abnormal_cell_differentiation | 1.77271362 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.77079508 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.75376851 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.75376851 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.75171597 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.73586139 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.72661722 |
| 41 | MP0001853_heart_inflammation | 1.72388032 |
| 42 | MP0005174_abnormal_tail_pigmentation | 1.71082648 |
| 43 | MP0002132_abnormal_respiratory_system | 1.69419927 |
| 44 | MP0001348_abnormal_lacrimal_gland | 1.67561942 |
| 45 | * MP0001845_abnormal_inflammatory_respons | 1.64722924 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.64543318 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.59095622 |
| 48 | MP0004264_abnormal_extraembryonic_tissu | 1.58588178 |
| 49 | * MP0000689_abnormal_spleen_morphology | 1.55563430 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.49041701 |
| 51 | * MP0002722_abnormal_immune_system | 1.48381825 |
| 52 | * MP0002429_abnormal_blood_cell | 1.43931264 |
| 53 | MP0000015_abnormal_ear_pigmentation | 1.40207723 |
| 54 | MP0010307_abnormal_tumor_latency | 1.39675541 |
| 55 | MP0000858_altered_metastatic_potential | 1.38201679 |
| 56 | MP0009764_decreased_sensitivity_to | 1.31471485 |
| 57 | * MP0000703_abnormal_thymus_morphology | 1.30849529 |
| 58 | MP0005310_abnormal_salivary_gland | 1.30154965 |
| 59 | MP0001873_stomach_inflammation | 1.28109529 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.26454962 |
| 61 | MP0008469_abnormal_protein_level | 1.25352658 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.20858343 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.20088833 |
| 64 | MP0002933_joint_inflammation | 1.16734838 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 1.16660328 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.16457102 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.16403956 |
| 68 | MP0003453_abnormal_keratinocyte_physiol | 1.12684669 |
| 69 | MP0001851_eye_inflammation | 1.12609991 |
| 70 | MP0003828_pulmonary_edema | 1.12473145 |
| 71 | MP0008961_abnormal_basal_metabolism | 1.07168420 |
| 72 | MP0000490_abnormal_crypts_of | 1.01350673 |
| 73 | MP0000371_diluted_coat_color | 1.00711811 |
| 74 | MP0008057_abnormal_DNA_replication | 0.99027924 |
| 75 | MP0000343_altered_response_to | 0.98159670 |
| 76 | MP0003091_abnormal_cell_migration | 0.97596384 |
| 77 | MP0009115_abnormal_fat_cell | 0.95939176 |
| 78 | MP0002254_reproductive_system_inflammat | 0.88894172 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 0.88731013 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 0.88728977 |
| 81 | MP0005390_skeleton_phenotype | 0.87300526 |
| 82 | MP0008004_abnormal_stomach_pH | 0.87220021 |
| 83 | MP0009763_increased_sensitivity_to | 0.86885215 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 0.86297573 |
| 85 | MP0002277_abnormal_respiratory_mucosa | 0.84015288 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.83274246 |
| 87 | MP0009840_abnormal_foam_cell | 0.80692946 |
| 88 | MP0005257_abnormal_intraocular_pressure | 0.80284200 |
| 89 | MP0003878_abnormal_ear_physiology | 0.78418966 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.78418966 |
| 91 | MP0008260_abnormal_autophagy | 0.77655714 |
| 92 | MP0003045_fibrosis | 0.76246137 |
| 93 | MP0003866_abnormal_defecation | 0.75706653 |
| 94 | MP0000609_abnormal_liver_physiology | 0.74405844 |
| 95 | MP0000767_abnormal_smooth_muscle | 0.72020618 |
| 96 | MP0008995_early_reproductive_senescence | 0.71781548 |
| 97 | MP0005166_decreased_susceptibility_to | 0.71312183 |
| 98 | MP0000604_amyloidosis | 0.70885500 |
| 99 | MP0001663_abnormal_digestive_system | 0.70231534 |
| 100 | MP0000383_abnormal_hair_follicle | 0.68677989 |
| 101 | MP0001346_abnormal_lacrimal_gland | 0.68543943 |
| 102 | MP0004185_abnormal_adipocyte_glucose | 0.67713042 |
| 103 | MP0003077_abnormal_cell_cycle | 0.67608202 |
| 104 | MP0000733_abnormal_muscle_development | 0.67319049 |
| 105 | MP0005023_abnormal_wound_healing | 0.66530670 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.66418639 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.66369174 |
| 108 | MP0003795_abnormal_bone_structure | 0.65053447 |
| 109 | * MP0000313_abnormal_cell_death | 0.61171711 |
| 110 | MP0005621_abnormal_cell_physiology | 0.60930625 |
| 111 | MP0001879_abnormal_lymphatic_vessel | 0.60732443 |
| 112 | MP0001986_abnormal_taste_sensitivity | 0.59027425 |
| 113 | MP0008007_abnormal_cellular_replicative | 0.58960652 |
| 114 | MP0001191_abnormal_skin_condition | 0.57800614 |
| 115 | MP0010094_abnormal_chromosome_stability | 0.57687478 |
| 116 | * MP0000249_abnormal_blood_vessel | 0.57274275 |
| 117 | MP0003191_abnormal_cellular_cholesterol | 0.56390543 |
| 118 | MP0003075_altered_response_to | 0.55543083 |
| 119 | MP0002163_abnormal_gland_morphology | 0.55443293 |
| 120 | MP0001919_abnormal_reproductive_system | 0.54734925 |
| 121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54217968 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.53903317 |
| 123 | MP0009931_abnormal_skin_appearance | 0.53705556 |
| 124 | MP0004381_abnormal_hair_follicle | 0.52243098 |
| 125 | MP0003943_abnormal_hepatobiliary_system | 0.52104235 |
| 126 | MP0002095_abnormal_skin_pigmentation | 0.50380084 |
| 127 | MP0001915_intracranial_hemorrhage | 0.49888036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.30045768 |
| 2 | Stomatitis (HP:0010280) | 6.17483339 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.86789869 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.68661425 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.58047154 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.65510844 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.37093799 |
| 8 | Optic neuritis (HP:0100653) | 4.37093799 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 4.15555545 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.08166950 |
| 11 | Orchitis (HP:0100796) | 4.06455557 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.01987288 |
| 13 | Myositis (HP:0100614) | 4.00412903 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.94373155 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 3.66499769 |
| 16 | Recurrent skin infections (HP:0001581) | 3.62950922 |
| 17 | Gingivitis (HP:0000230) | 3.58121429 |
| 18 | Recurrent viral infections (HP:0004429) | 3.54351476 |
| 19 | Vasculitis (HP:0002633) | 3.53963714 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 3.49227548 |
| 21 | Prostate neoplasm (HP:0100787) | 3.36056030 |
| 22 | Leukocytosis (HP:0001974) | 3.26416235 |
| 23 | Hematochezia (HP:0002573) | 3.25133356 |
| 24 | Obstructive lung disease (HP:0006536) | 3.12271617 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.12271617 |
| 26 | Increased IgE level (HP:0003212) | 3.11557851 |
| 27 | Pustule (HP:0200039) | 3.09282011 |
| 28 | Abnormality of T cell number (HP:0011839) | 3.07760949 |
| 29 | Periodontitis (HP:0000704) | 3.06350691 |
| 30 | T lymphocytopenia (HP:0005403) | 3.00252512 |
| 31 | Abnormality of T cell physiology (HP:0011840) | 2.93789930 |
| 32 | Pulmonary infiltrates (HP:0002113) | 2.88663283 |
| 33 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.88509944 |
| 34 | Thick nail (HP:0001805) | 2.86363152 |
| 35 | Eosinophilia (HP:0001880) | 2.84197588 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 2.79149273 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.79149273 |
| 38 | Cellulitis (HP:0100658) | 2.77838148 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.75529508 |
| 40 | Meningitis (HP:0001287) | 2.74557861 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.68044665 |
| 42 | Urticaria (HP:0001025) | 2.63465510 |
| 43 | IgM deficiency (HP:0002850) | 2.60373857 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.57757761 |
| 45 | Thyroiditis (HP:0100646) | 2.57515863 |
| 46 | Hypochromic anemia (HP:0001931) | 2.52988079 |
| 47 | Chest pain (HP:0100749) | 2.52544855 |
| 48 | Arterial thrombosis (HP:0004420) | 2.52098698 |
| 49 | Osteomyelitis (HP:0002754) | 2.51663928 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.48662427 |
| 51 | Increased IgM level (HP:0003496) | 2.43908875 |
| 52 | Chronic otitis media (HP:0000389) | 2.43171466 |
| 53 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.40401675 |
| 54 | Abnormality of the fingertips (HP:0001211) | 2.40116592 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.33589956 |
| 56 | Verrucae (HP:0200043) | 2.30919782 |
| 57 | Papilloma (HP:0012740) | 2.30919782 |
| 58 | Basal ganglia calcification (HP:0002135) | 2.30278035 |
| 59 | Slow saccadic eye movements (HP:0000514) | 2.28693958 |
| 60 | Abnormality of eosinophils (HP:0001879) | 2.27770182 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.27039996 |
| 62 | Viral hepatitis (HP:0006562) | 2.26585998 |
| 63 | Premature loss of primary teeth (HP:0006323) | 2.24514782 |
| 64 | Colitis (HP:0002583) | 2.24502248 |
| 65 | Hemoptysis (HP:0002105) | 2.24351335 |
| 66 | Granulocytopenia (HP:0001913) | 2.23840880 |
| 67 | Keratoconjunctivitis (HP:0001096) | 2.23093965 |
| 68 | Inflammation of the large intestine (HP:0002037) | 2.19905353 |
| 69 | Fatigue (HP:0012378) | 2.17973198 |
| 70 | Severe combined immunodeficiency (HP:0004430) | 2.17461446 |
| 71 | Amyloidosis (HP:0011034) | 2.17055994 |
| 72 | Lymphoma (HP:0002665) | 2.14691466 |
| 73 | Restrictive lung disease (HP:0002091) | 2.13634104 |
| 74 | Combined immunodeficiency (HP:0005387) | 2.12256865 |
| 75 | Gingival bleeding (HP:0000225) | 2.11803254 |
| 76 | Panhypogammaglobulinemia (HP:0003139) | 2.09686545 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.08843856 |
| 78 | Amaurosis fugax (HP:0100576) | 2.06178470 |
| 79 | Abnormality of T cells (HP:0002843) | 2.04393151 |
| 80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.04389347 |
| 81 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.04389347 |
| 82 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.04389347 |
| 83 | Gastrointestinal inflammation (HP:0004386) | 2.03456646 |
| 84 | Basal cell carcinoma (HP:0002671) | 2.03036080 |
| 85 | Cheilitis (HP:0100825) | 2.02605939 |
| 86 | Disinhibition (HP:0000734) | 2.02391778 |
| 87 | Persistence of primary teeth (HP:0006335) | 2.02040080 |
| 88 | Gangrene (HP:0100758) | 2.01686014 |
| 89 | Submucous cleft hard palate (HP:0000176) | 2.01105488 |
| 90 | Prolonged bleeding time (HP:0003010) | 1.98715682 |
| 91 | Axonal loss (HP:0003447) | 1.97840989 |
| 92 | Subacute progressive viral hepatitis (HP:0006572) | 1.96457145 |
| 93 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95666008 |
| 94 | Abnormality of B cell number (HP:0010975) | 1.95016413 |
| 95 | B lymphocytopenia (HP:0010976) | 1.95016413 |
| 96 | Anorexia (HP:0002039) | 1.95015620 |
| 97 | Stomach cancer (HP:0012126) | 1.94717091 |
| 98 | Lymphopenia (HP:0001888) | 1.94709713 |
| 99 | Recurrent sinusitis (HP:0011108) | 1.93778084 |
| 100 | Progressive hearing impairment (HP:0001730) | 1.93581355 |
| 101 | Myocardial infarction (HP:0001658) | 1.92521921 |
| 102 | Agammaglobulinemia (HP:0004432) | 1.92305410 |
| 103 | Leukopenia (HP:0001882) | 1.91034339 |
| 104 | Progressive external ophthalmoplegia (HP:0000590) | 1.89955037 |
| 105 | Tetraparesis (HP:0002273) | 1.89156105 |
| 106 | Abnormality of the columella (HP:0009929) | 1.88095494 |
| 107 | Epistaxis (HP:0000421) | 1.88034595 |
| 108 | Abnormality of the nasal septum (HP:0000419) | 1.87931322 |
| 109 | Pulmonary embolism (HP:0002204) | 1.86533901 |
| 110 | Abnormality of the endocardium (HP:0004306) | 1.86161640 |
| 111 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.86151101 |
| 112 | Abnormality of the pleura (HP:0002103) | 1.85162898 |
| 113 | Chronic diarrhea (HP:0002028) | 1.84978075 |
| 114 | Abnormality of the peritoneum (HP:0002585) | 1.84942003 |
| 115 | Recurrent lower respiratory tract infections (HP:0002783) | 1.84765150 |
| 116 | Progressive sensorineural hearing impairment (HP:0000408) | 1.84024926 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 1.83993189 |
| 118 | IgG deficiency (HP:0004315) | 1.83779287 |
| 119 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.83506864 |
| 120 | Acute hepatic failure (HP:0006554) | 1.82479992 |
| 121 | Neonatal hypoglycemia (HP:0001998) | 1.82195075 |
| 122 | Spontaneous hematomas (HP:0007420) | 1.82047851 |
| 123 | Polyneuropathy (HP:0001271) | 1.81419256 |
| 124 | Arthralgia (HP:0002829) | 1.80887593 |
| 125 | Metaphyseal cupping (HP:0003021) | 1.80877162 |
| 126 | Hypoplasia of the thymus (HP:0000778) | 1.80815202 |
| 127 | Recurrent bronchitis (HP:0002837) | 1.80773637 |
| 128 | Bone pain (HP:0002653) | 1.80240520 |
| 129 | IgA deficiency (HP:0002720) | 1.79652684 |
| 130 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79647873 |
| 131 | Osteolytic defects of the hand bones (HP:0009699) | 1.79647873 |
| 132 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77813729 |
| 133 | Gastrointestinal stroma tumor (HP:0100723) | 1.77053811 |
| 134 | Skin ulcer (HP:0200042) | 1.76964954 |
| 135 | Encephalitis (HP:0002383) | 1.75633174 |
| 136 | Large earlobe (HP:0009748) | 1.75262851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.64523003 |
| 2 | PRPF4B | 3.49499646 |
| 3 | TXK | 3.47163333 |
| 4 | MAP4K1 | 3.45363212 |
| 5 | IRAK3 | 3.34894101 |
| 6 | CDK12 | 3.00704884 |
| 7 | TBK1 | 2.98454294 |
| 8 | TYK2 | 2.86033708 |
| 9 | IRAK4 | 2.83263129 |
| 10 | IKBKE | 2.51544900 |
| 11 | IKBKB | 2.49792280 |
| 12 | JAK3 | 2.34755515 |
| 13 | SMG1 | 2.15506757 |
| 14 | RIPK4 | 2.12258993 |
| 15 | CHUK | 2.10694870 |
| 16 | TRIB3 | 1.95440680 |
| 17 | JAK1 | 1.85201768 |
| 18 | MAP3K10 | 1.77766499 |
| 19 | ZAP70 | 1.76892087 |
| 20 | KIT | 1.73261251 |
| 21 | BLK | 1.73022818 |
| 22 | MAP3K13 | 1.70895663 |
| 23 | RPS6KA4 | 1.63783853 |
| 24 | STK10 | 1.62926624 |
| 25 | SIK3 | 1.59483995 |
| 26 | SIK2 | 1.56962552 |
| 27 | PIM1 | 1.54461310 |
| 28 | TAOK3 | 1.53701223 |
| 29 | ITK | 1.51054733 |
| 30 | MARK3 | 1.47990506 |
| 31 | HCK | 1.42184008 |
| 32 | CSK | 1.29044627 |
| 33 | BRD4 | 1.28848761 |
| 34 | BTK | 1.26583000 |
| 35 | SYK | 1.26103455 |
| 36 | TEC | 1.23614725 |
| 37 | LCK | 1.19012007 |
| 38 | PIM2 | 1.13417608 |
| 39 | EPHB1 | 1.11440365 |
| 40 | CSF1R | 1.09674852 |
| 41 | EEF2K | 1.09602138 |
| 42 | TAOK1 | 1.06026803 |
| 43 | ICK | 1.05162927 |
| 44 | MAP3K1 | 1.05069523 |
| 45 | PKN2 | 1.00375500 |
| 46 | PTK6 | 0.99527135 |
| 47 | STK4 | 0.99490852 |
| 48 | TGFBR2 | 0.99213598 |
| 49 | KSR2 | 0.96497902 |
| 50 | MAP2K2 | 0.96342835 |
| 51 | CDK6 | 0.94493006 |
| 52 | MARK2 | 0.94267641 |
| 53 | CLK1 | 0.91358903 |
| 54 | JAK2 | 0.90840992 |
| 55 | ERN1 | 0.90523306 |
| 56 | FGFR3 | 0.89469531 |
| 57 | MST4 | 0.89125671 |
| 58 | LYN | 0.88920690 |
| 59 | MAPK11 | 0.86752255 |
| 60 | MAP3K3 | 0.84794588 |
| 61 | NLK | 0.84038817 |
| 62 | NEK9 | 0.82340588 |
| 63 | PDK1 | 0.81976337 |
| 64 | MAP2K3 | 0.81520265 |
| 65 | STK3 | 0.80904116 |
| 66 | TTN | 0.80204723 |
| 67 | EIF2AK2 | 0.76765346 |
| 68 | SIK1 | 0.76512025 |
| 69 | TNK2 | 0.75658016 |
| 70 | YES1 | 0.74565179 |
| 71 | INSRR | 0.74316135 |
| 72 | MELK | 0.71289161 |
| 73 | EPHA3 | 0.70669001 |
| 74 | SGK3 | 0.67683020 |
| 75 | FGR | 0.64905382 |
| 76 | GRK6 | 0.64215314 |
| 77 | PASK | 0.63762776 |
| 78 | TESK2 | 0.63599263 |
| 79 | MAP3K5 | 0.62559510 |
| 80 | TYRO3 | 0.62522822 |
| 81 | EGFR | 0.61487654 |
| 82 | CDK9 | 0.60579641 |
| 83 | ABL1 | 0.60051743 |
| 84 | PDPK1 | 0.58927209 |
| 85 | PDGFRB | 0.57990413 |
| 86 | SGK2 | 0.57291966 |
| 87 | RIPK1 | 0.56445600 |
| 88 | FGFR4 | 0.56441145 |
| 89 | PIK3CG | 0.56335085 |
| 90 | IRAK1 | 0.55952581 |
| 91 | MAP3K2 | 0.55817418 |
| 92 | TAOK2 | 0.55635608 |
| 93 | BMX | 0.54971894 |
| 94 | WNK1 | 0.54518955 |
| 95 | CDK4 | 0.54482913 |
| 96 | FES | 0.54261184 |
| 97 | NEK2 | 0.53230659 |
| 98 | CAMKK1 | 0.51530350 |
| 99 | NEK6 | 0.51221632 |
| 100 | MAPK12 | 0.50230008 |
| 101 | CDC42BPA | 0.47953774 |
| 102 | RPS6KA6 | 0.47444000 |
| 103 | CAMK1D | 0.47325679 |
| 104 | PBK | 0.47083592 |
| 105 | RPS6KB2 | 0.47064411 |
| 106 | PRKCQ | 0.46413115 |
| 107 | NUAK1 | 0.45270203 |
| 108 | MAPK7 | 0.45138133 |
| 109 | MAP3K7 | 0.45135898 |
| 110 | NME2 | 0.44838879 |
| 111 | CDK7 | 0.44389163 |
| 112 | MAPKAPK2 | 0.43168351 |
| 113 | BMPR2 | 0.43146162 |
| 114 | RAF1 | 0.42954263 |
| 115 | ATR | 0.42321699 |
| 116 | MAP3K11 | 0.42130783 |
| 117 | LRRK2 | 0.41667472 |
| 118 | ALK | 0.41375999 |
| 119 | RPS6KA2 | 0.40875523 |
| 120 | MATK | 0.39936926 |
| 121 | CAMK1G | 0.39866285 |
| 122 | RPS6KA5 | 0.39478110 |
| 123 | RPS6KC1 | 0.36093276 |
| 124 | RPS6KL1 | 0.36093276 |
| 125 | TRPM7 | 0.34948980 |
| 126 | HIPK2 | 0.34651780 |
| 127 | INSR | 0.34160975 |
| 128 | PAK4 | 0.33301980 |
| 129 | MAP3K8 | 0.33259834 |
| 130 | GSK3A | 0.32482354 |
| 131 | PRKCD | 0.31399649 |
| 132 | MTOR | 0.29241152 |
| 133 | RPS6KA1 | 0.28880397 |
| 134 | IRAK2 | 0.27651213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.05417680 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.05072529 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85612304 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.75078946 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.65384085 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.42436478 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.40782538 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.21120546 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.15812120 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.07303190 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.03620017 |
| 12 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.96674233 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.94921590 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.90602629 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.90203900 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.90031869 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.89101148 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.80821602 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.79876030 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.76671917 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.74350352 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.70625120 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67874680 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.65156478 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64206745 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62183959 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62119406 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61609700 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60196364 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56196114 |
| 31 | * Apoptosis_Homo sapiens_hsa04210 | 1.42471597 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41676753 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.39638330 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38792380 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.37229676 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.34623082 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27790490 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24687775 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24041633 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23741849 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.21412422 |
| 42 | Endometrial cancer_Homo sapiens_hsa05213 | 1.19514441 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13648800 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11897999 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11017389 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10726137 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.10448113 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.08679768 |
| 49 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04261028 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02987551 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 1.01707235 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00488988 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.97464853 |
| 54 | Thyroid cancer_Homo sapiens_hsa05216 | 0.96234821 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93660114 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91068989 |
| 57 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90776141 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85296477 |
| 59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83052936 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79986327 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78229386 |
| 62 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.76419112 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.76174990 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74948639 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74629837 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73091107 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72426155 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70156903 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68497163 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67784792 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.67584028 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67007565 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66466167 |
| 74 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65172816 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64767864 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.63790406 |
| 77 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.62240900 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59269068 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57727326 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55632565 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55363776 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53747654 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.52911330 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51105206 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50599597 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48944429 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.48586562 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48099924 |
| 89 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48077484 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47929079 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.47849261 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46660607 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45858566 |
| 94 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.44481028 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44297825 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.41435655 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41166911 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40509195 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39972397 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39959985 |
| 101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39548878 |
| 102 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36620862 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36414718 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34961885 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34960633 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34753733 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32535613 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.31838247 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31723694 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31621205 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.31224543 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30170538 |
| 113 | Spliceosome_Homo sapiens_hsa03040 | 0.28239068 |
| 114 | Homologous recombination_Homo sapiens_hsa03440 | 0.26451506 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26255641 |
| 116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.25711036 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24309016 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.23989789 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.22955958 |
| 120 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.22035652 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21957840 |

